关键数据
6.670今开
6.790最高
84.08K成交量
亏损市盈率 TTM
6.56市盈率动
--股息TTM
0.31%换手率
6.650昨收
6.600最低
389.09K成交额
亏损市盈率静
5.71市净率
0.00%股息率 TTM
-10.86%ROA
9.55552周最高
1.57量比
-14.67M净利润
27.14M总股本
-0.3681每股收益TTM
1.08Beta
-36.61%ROE
4.31052周最低
2.86%振幅
61.58%毛利率
183.36M总市值
-1.93回报/风险
3.36%风险率
最新
电话会议纪要

即将为您带来更多新闻,敬请期待。。。
Journey Medical Corp评分
0.12与上次评分对比预测8.00
财务诊断7.99
技术分析4.35
公司估值8.78
机构认同度5.00
风险评估3.91
分析师评级
买入评级
13.500目标均价
+109.63%涨幅空间
Journey Medical Corp 最新财报电话会记录
Journey Medical (DERM) 2026年第二季度业绩电话会议:Emrosi推动营收增长23%
Journey Medical 2026年第二季度业绩电话会议介绍了公司23%的营收增长、Emrosi处方量的加速增长、调整后EBITDA实现转正以及支付方覆盖范围的改善。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
Journey Medical Corp 简介
Journey Medical Corporation is a commercial-stage pharmaceutical company. The Company is focused on selling and marketing of the United States Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products, which have been approved FDA for sale in the United States, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox, and Luxamend. Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis. Accutane is an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne. Targadox is an oral doxycycline drug for adjunctive therapy for severe acne. Luxamend is a water-based emulsion formulated to provide moist healing environment.
行业药品
公司代码DERM
员工数量41
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| Fortress Biotech Inc | 15.74% |
|---|
| Maraoui (Claude) | 10.73% |
|---|
| Wasatch Global Investors Inc | 9.99% |
|---|
| Tang Capital Management, LLC | 8.69% |
|---|
| 股东类型 | 占比 |
|---|
| Hedge Fund | 21.80% |
|---|
| Investment Advisor/Hedge Fund | 17.26% |
|---|
| Individual Investor | 16.85% |
|---|
| Investment Advisor | 16.39% |
|---|
常见问题
Journey Medical Corp(DERM)的当前股价是多少?
Journey Medical Corp(DERM)的当前股价是 6.64。
Journey Medical Corp的股票代码是什么?
Journey Medical Corp的股票代码是DERM。
Journey Medical Corp股票的52周最高点是多少?
Journey Medical Corp股票的52周最高点是9.55。
Journey Medical Corp股票的52周最低点是多少?
Journey Medical Corp股票的52周最低点是4.31。
Journey Medical Corp的市值是多少?
Journey Medical Corp的市值是180.24M。
现在Journey Medical Corp(DERM)的股票是买入、持有还是卖出?
根据分析师评级,Journey Medical Corp(DERM)的总体评级为买入,目标价格为13.50。
Journey Medical Corp(DERM)股票的每股收益(EPS TTM)是多少
Journey Medical Corp(DERM)股票的每股收益(EPS TTM)是-0.37。